Milestone Pharmaceuticals (MIST) vs ProMIS Neurosciences (PMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ProMIS Neurosciences (PMN) has outperformed Milestone Pharmaceuticals (MIST) over the past year, losing 32.4% versus a loss of 63.6%. Over five years, MIST leads with a -87.2% price change compared with -95.9% for PMN. Milestone Pharmaceuticals is the larger company by market cap ($89.7 million vs $80.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MIST | PMN |
|---|---|---|
| Share price | $0.7203 | $9.00 |
| Market cap | $89.68M | $80.71M |
| 1-day change | -4.87% | -1.30% |
| YTD return | -62.51% | +33.53% |
| 1-year return | -63.60% | -32.44% |
| 5-year return | -87.17% | -95.95% |
| EPS (TTM) | $-0.68 | $-11.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.06 | $27.40 |
| 52-week low | $0.7096 | $6.27 |
| Distance from 52-week high | -76.46% | -67.15% |
| Average volume | 1.39M | 84.01K |
| Shares outstanding | 124.50M | 8.97M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PMN has outperformed MIST by 31.2 percentage points over the past year.
MIST vs PMN FAQ
Which is bigger, Milestone Pharmaceuticals or ProMIS Neurosciences?
Milestone Pharmaceuticals (MIST) is larger, with a market capitalization of $89.68M compared with $80.71M for ProMIS Neurosciences (PMN).
Which stock has performed better over the past year, MIST or PMN?
PMN returned -32.44% over the past 12 months, compared with -63.60% for MIST (price return, excluding dividends). Past performance does not predict future results.
Are Milestone Pharmaceuticals and ProMIS Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.